JPRN-UMIN000006570Completed未知
Change in level of dyspnea when oral morphine is administered to cancer patients - Change in level of dyspnea when oral morphine is administered to cancer patients
Central Japan Lung Study Group (CJLSG)0 sites80 target enrollmentStarted: October 20, 2011Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Clinical condition which can improve with other medication, such as pneumonia or heart failure is predominant. 2) Severe organ disfunction 3) History of serious allergy to morphine 4) Receiving pentazocine or buprenorphine 5) Previous registration history
Investigators
Similar Trials
Active, not recruiting
Phase 1
Morphine for dysnea in patients with lung fibrosisInterstitial Lung diseaseEUCTR2015-002533-22-DKAarhus University Hospital36
Recruiting
Phase 2
The effects of morphine on breathlessness and sleep in chronic obstructive pulmonary disease: A randomised, double-blind, placebo controlled cross-over studychronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseaseACTRN12621000752864Adelaide Institute for Sleep Health, Flinders University22
Recruiting
Phase 2
Comparison of the effect of morphine and pethidine injections into the pleural space to control postoperative pain in tracheotomy surgeriesPain control after thoracotomy.Acute post-thoracotomy painG89.12IRCT20230828059289N1Qazvin University of Medical Sciences72
Completed
Not Applicable
Phase I study of safety of morphine for dyspnea in patients with interstitial lung diseaseDyspnea in patients with interstitial lung diseaseJPRN-UMIN000016137on-Profit Organization JORTC12
Active, not recruiting
Phase 1
Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung DiseaseFibrotic Interstitial Lung DiseaseMedDRA version: 21.1Level: PTClassification code: 10022611Term: Interstitial lung disease Class: 100000004855CTIS2023-503700-81-00Aarhus University Hospital110